Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate

Documenti analoghi

• Protection against Mycobacterium leprae Infection by the ID83/GLA-SE and ID93/GLA-SE Vaccines Developed for Tuberculosis
  di: Duthie, Malcolm S., et al.
  Pubblicazione: (2014)
• Protection of mice from Mycobacterium tuberculosis by ID87/GLA-SE, a novel tuberculosis subunit vaccine candidate
  di: Windish, Hillarie Plessner, et al.
  Pubblicazione: (2011)
• Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model
  di: Baldwin, Susan L., et al.
  Pubblicazione: (2021)
• The ID93 Tuberculosis Vaccine Candidate Does Not Induce Sensitivity to Purified Protein Derivative
  di: Baldwin, Susan L., et al.
  Pubblicazione: (2014)
• Long-term protective efficacy with a BCG-prime ID93/GLA-SE boost regimen against the hyper-virulent Mycobacterium tuberculosis strain K in a mouse model
  di: Kwon, Kee Woong, et al.
  Pubblicazione: (2019)